APP and Alzheimer disease: The “mitochondrial cascade hypothesis” has been proposed to explain AD positing that mitochondrial dysfunction initiates pathological processes, including amyloid precursor protein (APP) dysregulation, amyloid-beta (Aβ) accumulation, and oxidative damage, which drive the onset and progression of AD [5,7].